Global Pharmaceutical Intermediate CDMO Supply, Demand and Key Producers, 2023-2029
The global Pharmaceutical Intermediate CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Pharmaceutical Intermediate CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Intermediate CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical Intermediate CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical Intermediate CDMO total market, 2018-2029, (USD Million)
Global Pharmaceutical Intermediate CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical Intermediate CDMO total market, key domestic companies and share, (USD Million)
Global Pharmaceutical Intermediate CDMO revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical Intermediate CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical Intermediate CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Pharmaceutical Intermediate CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cambrex, WR Grace, Esteve Quнmica, AGC Pharma Chemicals, Evonik, CordenPharma, Otsuka Chemical, Wavelength and KBI Biopharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical Intermediate CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical Intermediate CDMO Market, By Region:
1. How big is the global Pharmaceutical Intermediate CDMO market?
2. What is the demand of the global Pharmaceutical Intermediate CDMO market?
3. What is the year over year growth of the global Pharmaceutical Intermediate CDMO market?
4. What is the total value of the global Pharmaceutical Intermediate CDMO market?
5. Who are the major players in the global Pharmaceutical Intermediate CDMO market?
6. What are the growth factors driving the market demand?
This report studies the global Pharmaceutical Intermediate CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Intermediate CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical Intermediate CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical Intermediate CDMO total market, 2018-2029, (USD Million)
Global Pharmaceutical Intermediate CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical Intermediate CDMO total market, key domestic companies and share, (USD Million)
Global Pharmaceutical Intermediate CDMO revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical Intermediate CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical Intermediate CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Pharmaceutical Intermediate CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cambrex, WR Grace, Esteve Quнmica, AGC Pharma Chemicals, Evonik, CordenPharma, Otsuka Chemical, Wavelength and KBI Biopharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical Intermediate CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical Intermediate CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Small Molecule Cdmo
- Macromolecular Cdmo
- Pharmaceutical Company
- Biotechnology Company
- Others
- Cambrex
- WR Grace
- Esteve Quнmica
- AGC Pharma Chemicals
- Evonik
- CordenPharma
- Otsuka Chemical
- Wavelength
- KBI Biopharma
- Chengda Pharmaceuticals
- Apeloa Pharmaceutical
- Xi'an Manareco New Materials
- Shenzhen Sungening Bio-technology
- Chengdu D-innovation Pharmaceutical
- Huateng Pharma
1. How big is the global Pharmaceutical Intermediate CDMO market?
2. What is the demand of the global Pharmaceutical Intermediate CDMO market?
3. What is the year over year growth of the global Pharmaceutical Intermediate CDMO market?
4. What is the total value of the global Pharmaceutical Intermediate CDMO market?
5. Who are the major players in the global Pharmaceutical Intermediate CDMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pharmaceutical Intermediate CDMO Introduction
1.2 World Pharmaceutical Intermediate CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical Intermediate CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical Intermediate CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.3 China Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.4 Europe Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.5 Japan Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.8 India Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical Intermediate CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical Intermediate CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.2 World Pharmaceutical Intermediate CDMO Consumption Value by Region
2.2.1 World Pharmaceutical Intermediate CDMO Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical Intermediate CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.4 China Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.5 Europe Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.6 Japan Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.9 India Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL INTERMEDIATE CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical Intermediate CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical Intermediate CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical Intermediate CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical Intermediate CDMO in 2022
3.3 Pharmaceutical Intermediate CDMO Company Evaluation Quadrant
3.4 Pharmaceutical Intermediate CDMO Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical Intermediate CDMO Market: Region Footprint
3.4.2 Pharmaceutical Intermediate CDMO Market: Company Product Type Footprint
3.4.3 Pharmaceutical Intermediate CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical Intermediate CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical Intermediate CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical Intermediate CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical Intermediate CDMO Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical Intermediate CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical Intermediate CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical Intermediate CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical Intermediate CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical Intermediate CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical Intermediate CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical Intermediate CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical Intermediate CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical Intermediate CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Small Molecule Cdmo
5.2.2 Macromolecular Cdmo
5.3 Market Segment by Type
5.3.1 World Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical Intermediate CDMO Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical Intermediate CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical Intermediate CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical Intermediate CDMO Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical Intermediate CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cambrex
7.1.1 Cambrex Details
7.1.2 Cambrex Major Business
7.1.3 Cambrex Pharmaceutical Intermediate CDMO Product and Services
7.1.4 Cambrex Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Cambrex Recent Developments/Updates
7.1.6 Cambrex Competitive Strengths & Weaknesses
7.2 WR Grace
7.2.1 WR Grace Details
7.2.2 WR Grace Major Business
7.2.3 WR Grace Pharmaceutical Intermediate CDMO Product and Services
7.2.4 WR Grace Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 WR Grace Recent Developments/Updates
7.2.6 WR Grace Competitive Strengths & Weaknesses
7.3 Esteve Quнmica
7.3.1 Esteve Quнmica Details
7.3.2 Esteve Quнmica Major Business
7.3.3 Esteve Quнmica Pharmaceutical Intermediate CDMO Product and Services
7.3.4 Esteve Quнmica Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Esteve Quнmica Recent Developments/Updates
7.3.6 Esteve Quнmica Competitive Strengths & Weaknesses
7.4 AGC Pharma Chemicals
7.4.1 AGC Pharma Chemicals Details
7.4.2 AGC Pharma Chemicals Major Business
7.4.3 AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Product and Services
7.4.4 AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 AGC Pharma Chemicals Recent Developments/Updates
7.4.6 AGC Pharma Chemicals Competitive Strengths & Weaknesses
7.5 Evonik
7.5.1 Evonik Details
7.5.2 Evonik Major Business
7.5.3 Evonik Pharmaceutical Intermediate CDMO Product and Services
7.5.4 Evonik Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Evonik Recent Developments/Updates
7.5.6 Evonik Competitive Strengths & Weaknesses
7.6 CordenPharma
7.6.1 CordenPharma Details
7.6.2 CordenPharma Major Business
7.6.3 CordenPharma Pharmaceutical Intermediate CDMO Product and Services
7.6.4 CordenPharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 CordenPharma Recent Developments/Updates
7.6.6 CordenPharma Competitive Strengths & Weaknesses
7.7 Otsuka Chemical
7.7.1 Otsuka Chemical Details
7.7.2 Otsuka Chemical Major Business
7.7.3 Otsuka Chemical Pharmaceutical Intermediate CDMO Product and Services
7.7.4 Otsuka Chemical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Otsuka Chemical Recent Developments/Updates
7.7.6 Otsuka Chemical Competitive Strengths & Weaknesses
7.8 Wavelength
7.8.1 Wavelength Details
7.8.2 Wavelength Major Business
7.8.3 Wavelength Pharmaceutical Intermediate CDMO Product and Services
7.8.4 Wavelength Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Wavelength Recent Developments/Updates
7.8.6 Wavelength Competitive Strengths & Weaknesses
7.9 KBI Biopharma
7.9.1 KBI Biopharma Details
7.9.2 KBI Biopharma Major Business
7.9.3 KBI Biopharma Pharmaceutical Intermediate CDMO Product and Services
7.9.4 KBI Biopharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 KBI Biopharma Recent Developments/Updates
7.9.6 KBI Biopharma Competitive Strengths & Weaknesses
7.10 Chengda Pharmaceuticals
7.10.1 Chengda Pharmaceuticals Details
7.10.2 Chengda Pharmaceuticals Major Business
7.10.3 Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Product and Services
7.10.4 Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Chengda Pharmaceuticals Recent Developments/Updates
7.10.6 Chengda Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Apeloa Pharmaceutical
7.11.1 Apeloa Pharmaceutical Details
7.11.2 Apeloa Pharmaceutical Major Business
7.11.3 Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Product and Services
7.11.4 Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Apeloa Pharmaceutical Recent Developments/Updates
7.11.6 Apeloa Pharmaceutical Competitive Strengths & Weaknesses
7.12 Xi'an Manareco New Materials
7.12.1 Xi'an Manareco New Materials Details
7.12.2 Xi'an Manareco New Materials Major Business
7.12.3 Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Product and Services
7.12.4 Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Xi'an Manareco New Materials Recent Developments/Updates
7.12.6 Xi'an Manareco New Materials Competitive Strengths & Weaknesses
7.13 Shenzhen Sungening Bio-technology
7.13.1 Shenzhen Sungening Bio-technology Details
7.13.2 Shenzhen Sungening Bio-technology Major Business
7.13.3 Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Product and Services
7.13.4 Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Shenzhen Sungening Bio-technology Recent Developments/Updates
7.13.6 Shenzhen Sungening Bio-technology Competitive Strengths & Weaknesses
7.14 Chengdu D-innovation Pharmaceutical
7.14.1 Chengdu D-innovation Pharmaceutical Details
7.14.2 Chengdu D-innovation Pharmaceutical Major Business
7.14.3 Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Product and Services
7.14.4 Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Chengdu D-innovation Pharmaceutical Recent Developments/Updates
7.14.6 Chengdu D-innovation Pharmaceutical Competitive Strengths & Weaknesses
7.15 Huateng Pharma
7.15.1 Huateng Pharma Details
7.15.2 Huateng Pharma Major Business
7.15.3 Huateng Pharma Pharmaceutical Intermediate CDMO Product and Services
7.15.4 Huateng Pharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Huateng Pharma Recent Developments/Updates
7.15.6 Huateng Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical Intermediate CDMO Industry Chain
8.2 Pharmaceutical Intermediate CDMO Upstream Analysis
8.3 Pharmaceutical Intermediate CDMO Midstream Analysis
8.4 Pharmaceutical Intermediate CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pharmaceutical Intermediate CDMO Introduction
1.2 World Pharmaceutical Intermediate CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical Intermediate CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical Intermediate CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.3 China Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.4 Europe Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.5 Japan Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.3.8 India Pharmaceutical Intermediate CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical Intermediate CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical Intermediate CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.2 World Pharmaceutical Intermediate CDMO Consumption Value by Region
2.2.1 World Pharmaceutical Intermediate CDMO Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical Intermediate CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.4 China Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.5 Europe Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.6 Japan Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
2.9 India Pharmaceutical Intermediate CDMO Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL INTERMEDIATE CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical Intermediate CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical Intermediate CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical Intermediate CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical Intermediate CDMO in 2022
3.3 Pharmaceutical Intermediate CDMO Company Evaluation Quadrant
3.4 Pharmaceutical Intermediate CDMO Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical Intermediate CDMO Market: Region Footprint
3.4.2 Pharmaceutical Intermediate CDMO Market: Company Product Type Footprint
3.4.3 Pharmaceutical Intermediate CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical Intermediate CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical Intermediate CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical Intermediate CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical Intermediate CDMO Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical Intermediate CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical Intermediate CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical Intermediate CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical Intermediate CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical Intermediate CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical Intermediate CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical Intermediate CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical Intermediate CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical Intermediate CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Small Molecule Cdmo
5.2.2 Macromolecular Cdmo
5.3 Market Segment by Type
5.3.1 World Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical Intermediate CDMO Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical Intermediate CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical Intermediate CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical Intermediate CDMO Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical Intermediate CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cambrex
7.1.1 Cambrex Details
7.1.2 Cambrex Major Business
7.1.3 Cambrex Pharmaceutical Intermediate CDMO Product and Services
7.1.4 Cambrex Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Cambrex Recent Developments/Updates
7.1.6 Cambrex Competitive Strengths & Weaknesses
7.2 WR Grace
7.2.1 WR Grace Details
7.2.2 WR Grace Major Business
7.2.3 WR Grace Pharmaceutical Intermediate CDMO Product and Services
7.2.4 WR Grace Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 WR Grace Recent Developments/Updates
7.2.6 WR Grace Competitive Strengths & Weaknesses
7.3 Esteve Quнmica
7.3.1 Esteve Quнmica Details
7.3.2 Esteve Quнmica Major Business
7.3.3 Esteve Quнmica Pharmaceutical Intermediate CDMO Product and Services
7.3.4 Esteve Quнmica Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Esteve Quнmica Recent Developments/Updates
7.3.6 Esteve Quнmica Competitive Strengths & Weaknesses
7.4 AGC Pharma Chemicals
7.4.1 AGC Pharma Chemicals Details
7.4.2 AGC Pharma Chemicals Major Business
7.4.3 AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Product and Services
7.4.4 AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 AGC Pharma Chemicals Recent Developments/Updates
7.4.6 AGC Pharma Chemicals Competitive Strengths & Weaknesses
7.5 Evonik
7.5.1 Evonik Details
7.5.2 Evonik Major Business
7.5.3 Evonik Pharmaceutical Intermediate CDMO Product and Services
7.5.4 Evonik Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Evonik Recent Developments/Updates
7.5.6 Evonik Competitive Strengths & Weaknesses
7.6 CordenPharma
7.6.1 CordenPharma Details
7.6.2 CordenPharma Major Business
7.6.3 CordenPharma Pharmaceutical Intermediate CDMO Product and Services
7.6.4 CordenPharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 CordenPharma Recent Developments/Updates
7.6.6 CordenPharma Competitive Strengths & Weaknesses
7.7 Otsuka Chemical
7.7.1 Otsuka Chemical Details
7.7.2 Otsuka Chemical Major Business
7.7.3 Otsuka Chemical Pharmaceutical Intermediate CDMO Product and Services
7.7.4 Otsuka Chemical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Otsuka Chemical Recent Developments/Updates
7.7.6 Otsuka Chemical Competitive Strengths & Weaknesses
7.8 Wavelength
7.8.1 Wavelength Details
7.8.2 Wavelength Major Business
7.8.3 Wavelength Pharmaceutical Intermediate CDMO Product and Services
7.8.4 Wavelength Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Wavelength Recent Developments/Updates
7.8.6 Wavelength Competitive Strengths & Weaknesses
7.9 KBI Biopharma
7.9.1 KBI Biopharma Details
7.9.2 KBI Biopharma Major Business
7.9.3 KBI Biopharma Pharmaceutical Intermediate CDMO Product and Services
7.9.4 KBI Biopharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 KBI Biopharma Recent Developments/Updates
7.9.6 KBI Biopharma Competitive Strengths & Weaknesses
7.10 Chengda Pharmaceuticals
7.10.1 Chengda Pharmaceuticals Details
7.10.2 Chengda Pharmaceuticals Major Business
7.10.3 Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Product and Services
7.10.4 Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Chengda Pharmaceuticals Recent Developments/Updates
7.10.6 Chengda Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Apeloa Pharmaceutical
7.11.1 Apeloa Pharmaceutical Details
7.11.2 Apeloa Pharmaceutical Major Business
7.11.3 Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Product and Services
7.11.4 Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Apeloa Pharmaceutical Recent Developments/Updates
7.11.6 Apeloa Pharmaceutical Competitive Strengths & Weaknesses
7.12 Xi'an Manareco New Materials
7.12.1 Xi'an Manareco New Materials Details
7.12.2 Xi'an Manareco New Materials Major Business
7.12.3 Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Product and Services
7.12.4 Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Xi'an Manareco New Materials Recent Developments/Updates
7.12.6 Xi'an Manareco New Materials Competitive Strengths & Weaknesses
7.13 Shenzhen Sungening Bio-technology
7.13.1 Shenzhen Sungening Bio-technology Details
7.13.2 Shenzhen Sungening Bio-technology Major Business
7.13.3 Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Product and Services
7.13.4 Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Shenzhen Sungening Bio-technology Recent Developments/Updates
7.13.6 Shenzhen Sungening Bio-technology Competitive Strengths & Weaknesses
7.14 Chengdu D-innovation Pharmaceutical
7.14.1 Chengdu D-innovation Pharmaceutical Details
7.14.2 Chengdu D-innovation Pharmaceutical Major Business
7.14.3 Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Product and Services
7.14.4 Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Chengdu D-innovation Pharmaceutical Recent Developments/Updates
7.14.6 Chengdu D-innovation Pharmaceutical Competitive Strengths & Weaknesses
7.15 Huateng Pharma
7.15.1 Huateng Pharma Details
7.15.2 Huateng Pharma Major Business
7.15.3 Huateng Pharma Pharmaceutical Intermediate CDMO Product and Services
7.15.4 Huateng Pharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Huateng Pharma Recent Developments/Updates
7.15.6 Huateng Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical Intermediate CDMO Industry Chain
8.2 Pharmaceutical Intermediate CDMO Upstream Analysis
8.3 Pharmaceutical Intermediate CDMO Midstream Analysis
8.4 Pharmaceutical Intermediate CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pharmaceutical Intermediate CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical Intermediate CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical Intermediate CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical Intermediate CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical Intermediate CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical Intermediate CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical Intermediate CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical Intermediate CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical Intermediate CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical Intermediate CDMO Players in 2022
Table 12. World Pharmaceutical Intermediate CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical Intermediate CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical Intermediate CDMO Player
Table 15. Pharmaceutical Intermediate CDMO Market: Company Product Type Footprint
Table 16. Pharmaceutical Intermediate CDMO Market: Company Product Application Footprint
Table 17. Pharmaceutical Intermediate CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical Intermediate CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical Intermediate CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical Intermediate CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical Intermediate CDMO Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical Intermediate CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical Intermediate CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical Intermediate CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical Intermediate CDMO Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical Intermediate CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical Intermediate CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical Intermediate CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical Intermediate CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Cambrex Basic Information, Area Served and Competitors
Table 36. Cambrex Major Business
Table 37. Cambrex Pharmaceutical Intermediate CDMO Product and Services
Table 38. Cambrex Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Cambrex Recent Developments/Updates
Table 40. Cambrex Competitive Strengths & Weaknesses
Table 41. WR Grace Basic Information, Area Served and Competitors
Table 42. WR Grace Major Business
Table 43. WR Grace Pharmaceutical Intermediate CDMO Product and Services
Table 44. WR Grace Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. WR Grace Recent Developments/Updates
Table 46. WR Grace Competitive Strengths & Weaknesses
Table 47. Esteve Quнmica Basic Information, Area Served and Competitors
Table 48. Esteve Quнmica Major Business
Table 49. Esteve Quнmica Pharmaceutical Intermediate CDMO Product and Services
Table 50. Esteve Quнmica Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Esteve Quнmica Recent Developments/Updates
Table 52. Esteve Quнmica Competitive Strengths & Weaknesses
Table 53. AGC Pharma Chemicals Basic Information, Area Served and Competitors
Table 54. AGC Pharma Chemicals Major Business
Table 55. AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Product and Services
Table 56. AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AGC Pharma Chemicals Recent Developments/Updates
Table 58. AGC Pharma Chemicals Competitive Strengths & Weaknesses
Table 59. Evonik Basic Information, Area Served and Competitors
Table 60. Evonik Major Business
Table 61. Evonik Pharmaceutical Intermediate CDMO Product and Services
Table 62. Evonik Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Evonik Recent Developments/Updates
Table 64. Evonik Competitive Strengths & Weaknesses
Table 65. CordenPharma Basic Information, Area Served and Competitors
Table 66. CordenPharma Major Business
Table 67. CordenPharma Pharmaceutical Intermediate CDMO Product and Services
Table 68. CordenPharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. CordenPharma Recent Developments/Updates
Table 70. CordenPharma Competitive Strengths & Weaknesses
Table 71. Otsuka Chemical Basic Information, Area Served and Competitors
Table 72. Otsuka Chemical Major Business
Table 73. Otsuka Chemical Pharmaceutical Intermediate CDMO Product and Services
Table 74. Otsuka Chemical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Otsuka Chemical Recent Developments/Updates
Table 76. Otsuka Chemical Competitive Strengths & Weaknesses
Table 77. Wavelength Basic Information, Area Served and Competitors
Table 78. Wavelength Major Business
Table 79. Wavelength Pharmaceutical Intermediate CDMO Product and Services
Table 80. Wavelength Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Wavelength Recent Developments/Updates
Table 82. Wavelength Competitive Strengths & Weaknesses
Table 83. KBI Biopharma Basic Information, Area Served and Competitors
Table 84. KBI Biopharma Major Business
Table 85. KBI Biopharma Pharmaceutical Intermediate CDMO Product and Services
Table 86. KBI Biopharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. KBI Biopharma Recent Developments/Updates
Table 88. KBI Biopharma Competitive Strengths & Weaknesses
Table 89. Chengda Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Chengda Pharmaceuticals Major Business
Table 91. Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Product and Services
Table 92. Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Chengda Pharmaceuticals Recent Developments/Updates
Table 94. Chengda Pharmaceuticals Competitive Strengths & Weaknesses
Table 95. Apeloa Pharmaceutical Basic Information, Area Served and Competitors
Table 96. Apeloa Pharmaceutical Major Business
Table 97. Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Product and Services
Table 98. Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Apeloa Pharmaceutical Recent Developments/Updates
Table 100. Apeloa Pharmaceutical Competitive Strengths & Weaknesses
Table 101. Xi'an Manareco New Materials Basic Information, Area Served and Competitors
Table 102. Xi'an Manareco New Materials Major Business
Table 103. Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Product and Services
Table 104. Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Xi'an Manareco New Materials Recent Developments/Updates
Table 106. Xi'an Manareco New Materials Competitive Strengths & Weaknesses
Table 107. Shenzhen Sungening Bio-technology Basic Information, Area Served and Competitors
Table 108. Shenzhen Sungening Bio-technology Major Business
Table 109. Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Product and Services
Table 110. Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Shenzhen Sungening Bio-technology Recent Developments/Updates
Table 112. Shenzhen Sungening Bio-technology Competitive Strengths & Weaknesses
Table 113. Chengdu D-innovation Pharmaceutical Basic Information, Area Served and Competitors
Table 114. Chengdu D-innovation Pharmaceutical Major Business
Table 115. Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Product and Services
Table 116. Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Chengdu D-innovation Pharmaceutical Recent Developments/Updates
Table 118. Huateng Pharma Basic Information, Area Served and Competitors
Table 119. Huateng Pharma Major Business
Table 120. Huateng Pharma Pharmaceutical Intermediate CDMO Product and Services
Table 121. Huateng Pharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Pharmaceutical Intermediate CDMO Upstream (Raw Materials)
Table 123. Pharmaceutical Intermediate CDMO Typical Customers
List of Figure
Figure 1. Pharmaceutical Intermediate CDMO Picture
Figure 2. World Pharmaceutical Intermediate CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical Intermediate CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical Intermediate CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical Intermediate CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical Intermediate CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical Intermediate CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical Intermediate CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical Intermediate CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical Intermediate CDMO Markets in 2022
Figure 27. United States VS China: Pharmaceutical Intermediate CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical Intermediate CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical Intermediate CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical Intermediate CDMO Market Size Market Share by Type in 2022
Figure 31. Small Molecule Cdmo
Figure 32. Macromolecular Cdmo
Figure 33. World Pharmaceutical Intermediate CDMO Market Size Market Share by Type (2018-2029)
Figure 34. World Pharmaceutical Intermediate CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Pharmaceutical Intermediate CDMO Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical Company
Figure 37. Biotechnology Company
Figure 38. Others
Figure 39. Pharmaceutical Intermediate CDMO Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Pharmaceutical Intermediate CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical Intermediate CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical Intermediate CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical Intermediate CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical Intermediate CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical Intermediate CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical Intermediate CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical Intermediate CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical Intermediate CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical Intermediate CDMO Players in 2022
Table 12. World Pharmaceutical Intermediate CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical Intermediate CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical Intermediate CDMO Player
Table 15. Pharmaceutical Intermediate CDMO Market: Company Product Type Footprint
Table 16. Pharmaceutical Intermediate CDMO Market: Company Product Application Footprint
Table 17. Pharmaceutical Intermediate CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical Intermediate CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical Intermediate CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical Intermediate CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical Intermediate CDMO Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical Intermediate CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical Intermediate CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical Intermediate CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical Intermediate CDMO Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical Intermediate CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical Intermediate CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical Intermediate CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical Intermediate CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Cambrex Basic Information, Area Served and Competitors
Table 36. Cambrex Major Business
Table 37. Cambrex Pharmaceutical Intermediate CDMO Product and Services
Table 38. Cambrex Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Cambrex Recent Developments/Updates
Table 40. Cambrex Competitive Strengths & Weaknesses
Table 41. WR Grace Basic Information, Area Served and Competitors
Table 42. WR Grace Major Business
Table 43. WR Grace Pharmaceutical Intermediate CDMO Product and Services
Table 44. WR Grace Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. WR Grace Recent Developments/Updates
Table 46. WR Grace Competitive Strengths & Weaknesses
Table 47. Esteve Quнmica Basic Information, Area Served and Competitors
Table 48. Esteve Quнmica Major Business
Table 49. Esteve Quнmica Pharmaceutical Intermediate CDMO Product and Services
Table 50. Esteve Quнmica Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Esteve Quнmica Recent Developments/Updates
Table 52. Esteve Quнmica Competitive Strengths & Weaknesses
Table 53. AGC Pharma Chemicals Basic Information, Area Served and Competitors
Table 54. AGC Pharma Chemicals Major Business
Table 55. AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Product and Services
Table 56. AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AGC Pharma Chemicals Recent Developments/Updates
Table 58. AGC Pharma Chemicals Competitive Strengths & Weaknesses
Table 59. Evonik Basic Information, Area Served and Competitors
Table 60. Evonik Major Business
Table 61. Evonik Pharmaceutical Intermediate CDMO Product and Services
Table 62. Evonik Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Evonik Recent Developments/Updates
Table 64. Evonik Competitive Strengths & Weaknesses
Table 65. CordenPharma Basic Information, Area Served and Competitors
Table 66. CordenPharma Major Business
Table 67. CordenPharma Pharmaceutical Intermediate CDMO Product and Services
Table 68. CordenPharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. CordenPharma Recent Developments/Updates
Table 70. CordenPharma Competitive Strengths & Weaknesses
Table 71. Otsuka Chemical Basic Information, Area Served and Competitors
Table 72. Otsuka Chemical Major Business
Table 73. Otsuka Chemical Pharmaceutical Intermediate CDMO Product and Services
Table 74. Otsuka Chemical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Otsuka Chemical Recent Developments/Updates
Table 76. Otsuka Chemical Competitive Strengths & Weaknesses
Table 77. Wavelength Basic Information, Area Served and Competitors
Table 78. Wavelength Major Business
Table 79. Wavelength Pharmaceutical Intermediate CDMO Product and Services
Table 80. Wavelength Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Wavelength Recent Developments/Updates
Table 82. Wavelength Competitive Strengths & Weaknesses
Table 83. KBI Biopharma Basic Information, Area Served and Competitors
Table 84. KBI Biopharma Major Business
Table 85. KBI Biopharma Pharmaceutical Intermediate CDMO Product and Services
Table 86. KBI Biopharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. KBI Biopharma Recent Developments/Updates
Table 88. KBI Biopharma Competitive Strengths & Weaknesses
Table 89. Chengda Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Chengda Pharmaceuticals Major Business
Table 91. Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Product and Services
Table 92. Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Chengda Pharmaceuticals Recent Developments/Updates
Table 94. Chengda Pharmaceuticals Competitive Strengths & Weaknesses
Table 95. Apeloa Pharmaceutical Basic Information, Area Served and Competitors
Table 96. Apeloa Pharmaceutical Major Business
Table 97. Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Product and Services
Table 98. Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Apeloa Pharmaceutical Recent Developments/Updates
Table 100. Apeloa Pharmaceutical Competitive Strengths & Weaknesses
Table 101. Xi'an Manareco New Materials Basic Information, Area Served and Competitors
Table 102. Xi'an Manareco New Materials Major Business
Table 103. Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Product and Services
Table 104. Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Xi'an Manareco New Materials Recent Developments/Updates
Table 106. Xi'an Manareco New Materials Competitive Strengths & Weaknesses
Table 107. Shenzhen Sungening Bio-technology Basic Information, Area Served and Competitors
Table 108. Shenzhen Sungening Bio-technology Major Business
Table 109. Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Product and Services
Table 110. Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Shenzhen Sungening Bio-technology Recent Developments/Updates
Table 112. Shenzhen Sungening Bio-technology Competitive Strengths & Weaknesses
Table 113. Chengdu D-innovation Pharmaceutical Basic Information, Area Served and Competitors
Table 114. Chengdu D-innovation Pharmaceutical Major Business
Table 115. Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Product and Services
Table 116. Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Chengdu D-innovation Pharmaceutical Recent Developments/Updates
Table 118. Huateng Pharma Basic Information, Area Served and Competitors
Table 119. Huateng Pharma Major Business
Table 120. Huateng Pharma Pharmaceutical Intermediate CDMO Product and Services
Table 121. Huateng Pharma Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Pharmaceutical Intermediate CDMO Upstream (Raw Materials)
Table 123. Pharmaceutical Intermediate CDMO Typical Customers
List of Figure
Figure 1. Pharmaceutical Intermediate CDMO Picture
Figure 2. World Pharmaceutical Intermediate CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical Intermediate CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical Intermediate CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical Intermediate CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical Intermediate CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical Intermediate CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical Intermediate CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical Intermediate CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical Intermediate CDMO Markets in 2022
Figure 27. United States VS China: Pharmaceutical Intermediate CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical Intermediate CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical Intermediate CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical Intermediate CDMO Market Size Market Share by Type in 2022
Figure 31. Small Molecule Cdmo
Figure 32. Macromolecular Cdmo
Figure 33. World Pharmaceutical Intermediate CDMO Market Size Market Share by Type (2018-2029)
Figure 34. World Pharmaceutical Intermediate CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Pharmaceutical Intermediate CDMO Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical Company
Figure 37. Biotechnology Company
Figure 38. Others
Figure 39. Pharmaceutical Intermediate CDMO Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
